CRMI China Regenerative Medicine International L : Fund Invested Completes Acquisition of U.S Cosmeceuticals Brand

[Group News] China Regenerative Medicine International Limited (Stock Code: 8158.HK) Fund Invested Completes Acquisition of U.S Cosmeceuticals Brand – Obagi. Hong Kong, [13 November 2017] – China Regenerative Medicine International Limited (“China Regenerative Medicine” or “the Company”, stock code: 8158.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.